tolazamide has been researched along with c-peptide in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (71.43) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Friedberg, SJ; Pugh, JA; Ramirez, G; Sawyer, J; Tuley, M; Wagner, ML | 1 |
| Faro, B; McCormick, KL; Mick, GJ; Sanders, R; Stoler, P | 1 |
| Birkenholz, MR; Kabadi, UM | 1 |
| Bell, P; Firth, R; Marsh, M; Rizza, RA | 1 |
| Boden, G; Elsenhans, VD; Leiman, SM; Longnecker, MP; Owen, OE | 1 |
| Bell, PM; Firth, RG; Rizza, RA | 1 |
| Kitabchi, AE; Lawson-Grant, V; Radparvar, A; Soria, AG | 1 |
1 review(s) available for tolazamide and c-peptide
| Article | Year |
|---|---|
Is combination sulfonylurea and insulin therapy useful in NIDDM patients? A metaanalysis.
Topics: Blood Glucose; C-Peptide; Chlorpropamide; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Gliclazide; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; MEDLINE; Meta-Analysis as Topic; Middle Aged; Periodicals as Topic; Sulfonylurea Compounds; Tolazamide; Treatment Outcome; United States | 1992 |
7 trial(s) available for tolazamide and c-peptide
| Article | Year |
|---|---|
Is combination sulfonylurea and insulin therapy useful in NIDDM patients? A metaanalysis.
Topics: Blood Glucose; C-Peptide; Chlorpropamide; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Gliclazide; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; MEDLINE; Meta-Analysis as Topic; Middle Aged; Periodicals as Topic; Sulfonylurea Compounds; Tolazamide; Treatment Outcome; United States | 1992 |
Adjunctive use of tolazamide in newly-diagnosed diabetic children.
Topics: Adolescent; Blood Glucose; C-Peptide; Child; Child, Preschool; Diabetes Mellitus, Type 1; Double-Blind Method; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Insulin; Male; Prospective Studies; Tolazamide | 1990 |
Improved metabolic control in insulin-dependent diabetes mellitus with insulin and tolazamide.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Double-Blind Method; Drug Therapy, Combination; Glycated Hemoglobin; Glycosuria; Humans; Insulin; Middle Aged; Random Allocation; Tolazamide | 1988 |
Effects of tolazamide and exogenous insulin on pattern of postprandial carbohydrate metabolism in patients with non-insulin-dependent diabetes mellitus. Results of randomized crossover trial.
Topics: Blood Glucose; C-Peptide; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Dietary Carbohydrates; Female; Food; Glucose; Humans; Insulin; Kinetics; Liver; Male; Middle Aged; Random Allocation; Tolazamide | 1987 |
Insulin and a sulfonylurea agent in non-insulin-dependent diabetes mellitus.
Topics: Administration, Oral; Adult; Aged; Blood Glucose; C-Peptide; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Insulin; Male; Middle Aged; Random Allocation; Time Factors; Tolazamide | 1986 |
Effects of tolazamide and exogenous insulin on insulin action in patients with non-insulin-dependent diabetes mellitus.
Topics: Blood Glucose; C-Peptide; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Erythrocytes; Glycated Hemoglobin; Humans; Insulin; Insulin Resistance; Middle Aged; Random Allocation; Tolazamide | 1986 |
Combined therapy of insulin and tolazamide decreases insulin requirement and serum triglycerides in obese patients with noninsulin-dependent diabetes mellitus.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Cholesterol; Diabetes Mellitus; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Insulin, Isophane; Middle Aged; Obesity; Prospective Studies; Random Allocation; Tolazamide; Triglycerides | 1987 |